GSK Begins Trials of Swine Flu Vaccine in Germany

by VR Sreeraman on  August 15, 2009 at 10:14 AM Drug News   - G J E 4
British pharmaceuticals group GlaxoSmithKline said Friday it had begun clinical trials in Germany of a vaccine to combat the swine flu pandemic, with results expected from next month.
 GSK Begins Trials of Swine Flu Vaccine in Germany
GSK Begins Trials of Swine Flu Vaccine in Germany

"The first clinical trial, being conducted in Germany, will assess the use of the vaccine in healthy adults. Initial data is expected to be available for sharing with regulatory authorities in September," GSK said in a statement.

GSK added further trials of the vaccine, called Pandemic (H1N1) 2009, would begin over coming weeks across Europe, Canada and the United States to cover infants, children, adults and the elderly.

GSK is among a select few leading pharmaceutical companies that are creating vaccines against the A(H1N1) virus for millions of people to take ahead of the northern hemisphere winter so that they avoid contracting the illness.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like